Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.
Eli Lilly is injecting some funding …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Jonathan Malek, SVP and General Manager, Provider Business, Veradigm The last few years have emphasized the need for high-quality healthcare for patients that is accessible
KSQ Therapeutics quickly lined up another Big Pharma partnership, this time allying with Roche in oncology, and it plans to use the cash windfall to
Teva’s drug ingredients unit is apparently not making the pivot. Less than a year into its “pivot to growth” strategy, Teva has announced plans to